0000950170-24-026086.txt : 20240305
0000950170-24-026086.hdr.sgml : 20240305
20240305163731
ACCESSION NUMBER: 0000950170-24-026086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rollins Emily
CENTRAL INDEX KEY: 0001847014
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32431
FILM NUMBER: 24721330
MAIL ADDRESS:
STREET 1: C/O DOLBY LABORATORIES, INC.
STREET 2: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dolby Laboratories, Inc.
CENTRAL INDEX KEY: 0001308547
STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794]
ORGANIZATION NAME: 05 Real Estate & Construction
IRS NUMBER: 900199783
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0927
BUSINESS ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415 558 0200
MAIL ADDRESS:
STREET 1: 1275 MARKET STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
4
1
ownership.xml
4
X0508
4
2024-03-01
0001308547
Dolby Laboratories, Inc.
DLB
0001847014
Rollins Emily
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO
CA
94103
true
false
false
false
false
Class A Common Stock
2024-03-01
4
S
false
1000
80.88
D
7493
D
Shares held following the reported transaction include 2,952 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 8, 2023 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.
/s/ Daniel Rodriguez as Attorney-in-Fact for Emily Rollins
2024-03-05